3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Vitamin D Deficiency
2
Neoplasms
2
Myelodysplastic Syndromes
2
Renal Insufficiency, Chronic
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia
1
Hematologic Diseases
1
Cardiovascular Diseases
1
Bone Diseases, Metabolic
1
Anemia, Refractory, with Excess of Blasts
1
Anemia, Refractory
1
Anemia, Aplastic
1
Anemia
1
Interventions
ziprasidone
1
peginesatide
1
hematide
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Fosfomycin
1
Clozapine
1
Ciprofloxacin
1
Cidofovir
1
Cholecalciferol
1
Cefepime
1
Bosentan
1
Aminocaproic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Renal Insufficiency, Chronic
×
Cholecalciferol
×
Classical hematology
×
Clear all
NCT01817699
2019-02-04
CANDLE-KIT
CANDLE-KIT Trial Study Group
Phase 4
Terminated
161 enrolled